We describe the first time-resolved immunofluorometric assay for creatine kinase (EC 2.7.3.2) isoenzyme MB (CK-MB) in serum. The assay is based on the formation of the complex: solid-phase anti-CK-MB-CK-MB-biotinylated anti-CK-BB-streptavidin-BCPDA-Eu3+, where anti-CK-MB and anti-CK-BB are monoclonal antibodies against the CK isoenzymes MB and BB, respectively, and BCPDA is the europium chelator 4,7-bis(chlorosulfophenyl)-1,10-phenanthroline-2,9-dicarboxylic acid. The solid-phase complex is fluorescent and is measured on the dry solid-phase (microtiter well) in a specially designed time-resolved fluorometer that uses laser excitation. The assay requires 25 μL of serum and is not affected by the presence of either CK-MM (up to 5000 μg/L) or CK-BB (up to 1000 μg/L) in the sample. Precision and accuracy indices for the assay were satisfactory.
CITATION STYLE
Lianidou, E. S., Christopoulos, T. K., & Diamandis, E. P. (1990). Assay of creatine kinase isoenzyme MB in serum with time-resolved immunofluorometry. Clinical Chemistry, 36(9), 1679–1683. https://doi.org/10.1093/clinchem/36.9.1679
Mendeley helps you to discover research relevant for your work.